Showing results (951-960 of 4,505) with videos related to
Sort By:
Pageof 451
Advances in Therapy|May 8, 2025
Dupilumab Efficacy in Children with Atopic Dermatitis with Different Phenotypes and Endotypes: A Case SeriesAna B Rossi, Adriana M Mello, Joseph ZahnAdvances in Therapy|November 7, 2025
Development and Content Evaluation of the Eating Behavior and Appetite Questionnaire (EBAQ) for Individuals with ObesityChisom Kanu, Claudine Clucas, Anne Skalicky, et al.Advances in Therapy|November 1, 2025
Retrospective Analysis of Racial Differences in Treatment Patterns and Prostate-Specific Antigen Responses Among Patients with Prostate Cancer Treated with Relugolix in the Veterans Health AdministrationStephen J Freedland, Krishnan Ramaswamy, Abhishek Kavati, et al.Advances in Therapy|October 9, 2025
Immunosuppressive Therapy for Pulmonary Arterial Hypertension Associated with Connective Tissue Diseases: Insights from Japanese RegistryYudai Tamura, Yuichi Tamura, Ryo Takemura, et al.Advances in Therapy|October 6, 2025
The Global Patient Perspective on Uncontrolled Moderate-to-Severe Asthma: Reducing Delays in Diagnosis and TreatmentKaren Rance, Brenda Young, Gretchen McCreary, et al.Advances in Therapy|October 6, 2025
Quantifying the Clinical and Economic Burden of Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in England: A Retrospective Cohort StudyFrancesca Kinsella, Nadia Quignot, Stephanie H Read, et al.Advances in Therapy|September 27, 2025
Peak Nasal Inspiratory Flow and the Association with Nasal Obstruction in Patients with Severe CRSwNP from the SINUS-24/-52 StudiesMartin Desrosiers, Scott Nash, Andrew Lane, et al.Advances in Therapy|August 19, 2025
Identifying Parameters Associated with Delayed Diagnosis in Thrombotic Antiphospholipid Syndrome: Data from China Prospective APS CohortRuijie Mo, Yuan Zhao, Hui Jiang, et al.Advances in Therapy|September 8, 2025
Design of Two Randomized, Placebo-Controlled, Phase 3 Trials of Deucravacitinib, an Oral, Selective, Allosteric TYK2 Inhibitor, in Systemic Lupus ErythematosusCristina Arriens, Eric F Morand, Anca D Askanase, et al.Advances in Therapy|September 8, 2025
Switching Patients with Schizophrenia from Intramuscular Paliperidone Palmitate Once Monthly to TV-46000, a Long-Acting Subcutaneous Antipsychotic: Population Pharmacokinetic-Based StrategiesItay Perlstein, Jonathan Meyer, Ziqi Yue, et al.Pageof 451